Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.
van der Laan AM, Hirsch A, Robbers LF, Nijveldt R, Lommerse I, Delewi R, van der Vleuten PA, Biemond BJ, Zwaginga JJ, van der Giessen WJ, Zijlstra F, van Rossum AC, Voermans C, van der Schoot CE, Piek JJ. van der Laan AM, et al. Among authors: van der vleuten pa. Am Heart J. 2012 Jan;163(1):57-65.e2. doi: 10.1016/j.ahj.2011.09.002. Epub 2011 Nov 23. Am Heart J. 2012. PMID: 22172437 Free article.
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators. Hirsch A, et al. Among authors: van rossum ac, van der vleuten pa. Am Heart J. 2006 Sep;152(3):434-41. doi: 10.1016/j.ahj.2006.02.007. Am Heart J. 2006. PMID: 16923409
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F. Hirsch A, et al. Among authors: van rossum ac, van der vleuten pa, van der giessen wj. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337. Catheter Cardiovasc Interv. 2008. PMID: 18288734 Clinical Trial.
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F; HEBE Investigators. Hirsch A, et al. Among authors: van der vleuten pa. Eur Heart J. 2011 Jul;32(14):1736-47. doi: 10.1093/eurheartj/ehq449. Epub 2010 Dec 10. Eur Heart J. 2011. PMID: 21148540 Clinical Trial.
Pathological Q waves in myocardial infarction in patients treated by primary PCI.
Delewi R, Ijff G, van de Hoef TP, Hirsch A, Robbers LF, Nijveldt R, van der Laan AM, van der Vleuten PA, Lucas C, Tijssen JG, van Rossum AC, Zijlstra F, Piek JJ. Delewi R, et al. Among authors: van der vleuten pa. JACC Cardiovasc Imaging. 2013 Mar;6(3):324-31. doi: 10.1016/j.jcmg.2012.08.018. Epub 2013 Feb 20. JACC Cardiovasc Imaging. 2013. PMID: 23433932 Free article.
Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction.
Robbers LF, Delewi R, Nijveldt R, Hirsch A, Beek AM, Kemme MJ, van Beurden Y, van der Laan AM, van der Vleuten PA, Tio RA, Zijlstra F, Piek JJ, van Rossum AC. Robbers LF, et al. Among authors: van der vleuten pa. Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1150-8. doi: 10.1093/ehjci/jet111. Epub 2013 Jun 13. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23764484 Clinical Trial.
Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study.
Robbers LF, Nijveldt R, Beek AM, Hirsch A, van der Laan AM, Delewi R, van der Vleuten PA, Tio RA, Tijssen JG, Hofman MB, Piek JJ, Zijlstra F, van Rossum AC; HEBE Investigators. Robbers LF, et al. Among authors: van der vleuten pa. Radiology. 2014 Jul;272(1):113-22. doi: 10.1148/radiol.14131121. Epub 2014 Mar 8. Radiology. 2014. PMID: 24617731 Clinical Trial.
Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction.
Delewi R, van der Laan AM, Robbers LF, Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, Tio RA, Waltenberger J, Ten Berg JM, Doevendans PA, Gehlmann HR, van Rossum AC, Piek JJ, Zijlstra F; HEBE investigators. Delewi R, et al. Among authors: van der vleuten pa. Heart. 2015 Mar;101(5):363-8. doi: 10.1136/heartjnl-2014-305892. Epub 2014 Oct 7. Heart. 2015. PMID: 25294647 Clinical Trial.
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.
van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. van der Laan A, et al. Among authors: van rossum ac, van der vleuten pa, van der giessen wj. Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194. Neth Heart J. 2008. PMID: 19127324 Free PMC article.
36 results